Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
36,035,033
-
Share change
-
+6,529,724
-
Total reported value
-
$2,613,664,662
-
Put/Call ratio
-
91%
-
Price per share
-
$72.49
-
Number of holders
-
140
-
Value change
-
+$445,147,637
-
Number of buys
-
94
-
Number of sells
-
57
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2021
As of 30 Sep 2021 NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) had 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,035,033 shares of stock of the company.
Largest 10 holders included HHLR ADVISORS, LTD., PRICE T ROWE ASSOCIATES INC /MD/, Cederberg Capital Ltd, BlackRock Inc., Zeal Asset Management Ltd, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, PICTET ASSET MANAGEMENT SA, and PRINCIPAL FINANCIAL GROUP INC.
This table shows 140 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.